Metabolomics Workbench : NIH Data Repository

Analysis	Metabolite Name	Measured Value	Units	CASE_CONTROL	Chemotherapy	Drug	Race	TIMEPOINT	Tamoxyfen	Taxane
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	14016	Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	18024	Peak area	Control	N	Letrozole	Black	3 Month	N	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	18363	Peak area	Case	N	Letrozole	Black	3 Month	N	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	18595	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	18599	Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	19396	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	20218	Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	20815	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	20954	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	22307	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	22576	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	22591	Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	22752	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	23037	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	23237	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	23721	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	24310	Peak area	Case	N	Exemestane	Black	3 Month	N	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	24358	Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	24396	Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	24502	Peak area	Control	N	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	24529	Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	24564	Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	24740	Peak area	Case	N	Letrozole	Black	Baseline	N	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	24815	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	24817	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	24979	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	25257	Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	25563	Peak area	Control	Y	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	25608	Peak area	Case	Y	Exemestane	Black	Baseline	N	Y
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	25723	Peak area	Control	Y	Exemestane	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	25842	Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	25996	Peak area	Control	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	26041	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	26271	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	26730	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	26737	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	27232	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	27560	Peak area	Control	N	Letrozole	Black	Baseline	N	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	27587	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	27775	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	28065	Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	28289	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	28376	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	28586	Peak area	Control	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	29090	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	29132	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	29469	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	29612	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	30412	Peak area	Control	Y	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	30440	Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	30677	Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	31076	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	31140	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	31153	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	31298	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	32911	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	33274	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	33575	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	33744	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	33806	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	33907	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	34869	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	35056	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	35775	Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	36883	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	37360	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	37402	Peak area	Control	Y	Exemestane	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	37547	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	37667	Peak area	Case	N	Exemestane	Black	Baseline	N	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	39557	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	39608	Peak area	Control	N	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	39786	Peak area	Control	N	Exemestane	Black	3 Month	Y	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	40028	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	40436	Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	40580	Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	41148	Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	41603	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	41698	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	41967	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	42247	Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	42918	Peak area	Case	Y	Exemestane	Black	3 Month	N	Y
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	43201	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	44008	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	44796	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	47808	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	50550	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	51175	Peak area	Control	N	Exemestane	Black	Baseline	Y	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	51578	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	52116	Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	52865	Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	53298	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	54245	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	54654	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	55439	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	55581	Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	56121	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	68689	Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	69232	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	73764	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+H)+	75358	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+	2323	Peak area	Control	Y	Exemestane	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+	2788	Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+	2833	Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+	2929	Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+	2976	Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+	3502	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+	3643	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+	3645	Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+	3650	Peak area	Case	N	Exemestane	Black	Baseline	N	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+	3742	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+	3971	Peak area	Control	N	Letrozole	Black	Baseline	N	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+	4018	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+	4167	Peak area	Case	Y	Exemestane	Black	Baseline	N	Y
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+	4216	Peak area	Control	N	Letrozole	Black	3 Month	N	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+	4222	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+	4231	Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+	4275	Peak area	Control	Y	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+	4480	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+	4589	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+	4666	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+	4680	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+	4779	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+	4789	Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+	4814	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+	5113	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+	5147	Peak area	Control	Y	Exemestane	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+	5282	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+	5378	Peak area	Control	Y	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+	5665	Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+	5743	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+	5802	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+	5908	Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+	6148	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+	6305	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+	6512	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+	6530	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+	6860	Peak area	Case	Y	Exemestane	Black	3 Month	N	Y
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+	7128	Peak area	Control	N	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+	7156	Peak area	Control	N	Exemestane	Black	3 Month	Y	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+	7318	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+	7367	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+	7788	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+	8049	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+	8285	Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+	8404	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+	10118	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+	10291	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+	12038	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+		Peak area	Case	N	Exemestane	Black	3 Month	N	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+		Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+		Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+		Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+		Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+		Peak area	Case	N	Letrozole	Black	3 Month	N	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+		Peak area	Case	N	Letrozole	Black	Baseline	N	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+		Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+		Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+		Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+		Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+		Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+		Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+		Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+		Peak area	Control	N	Exemestane	Black	Baseline	Y	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+		Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+		Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+		Peak area	Control	N	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+		Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+		Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+		Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+		Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+		Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+		Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+		Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+		Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+		Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+		Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	LYSINE (CAS# 56-87-1); (M+NA)+		Peak area	Control	Y	Letrozole	White	Baseline	Y	Y